Contraceptives-Europe Market Status and Trend Report 2013-2023
Report Summary
Contraceptives-Europe Market Status and Trend Report 2013-2023 offers a comprehensive analysis on Contraceptives industry, standing on the readers’ perspective, delivering detailed market data and penetrating insights. No matter the client is industry insider, potential entrant or investor, the report will provides useful data and information. Key questions answered by this report include:
Whole Europe and Regional Market Size of Contraceptives 2013-2017, and development forecast 2018-2023
Main market players of Contraceptives in Europe, with company and product introduction, position in the Contraceptives market
Market status and development trend of Contraceptives by types and applications
Cost and profit status of Contraceptives, and marketing status
Market growth drivers and challenges
The report segments the Europe Contraceptives market as:
Europe Contraceptives Market: Regional Segment Analysis (Regional Consumption Volume, Consumption Volume, Revenue and Growth Rate 2013-2023)
Germany
United Kingdom
France
Italy
Spain
Benelux
Russia
Europe Contraceptives Market: Product Type Segment Analysis (Consumption Volume, Average Price, Revenue, Market Share and Trend 2013-2023):
Oral Contraceptive Pills
Injectables
Topical
Europe Contraceptives Market: Application Segment Analysis (Consumption Volume and Market Share 2013-2023; Downstream Customers and Market Analysis)
Male
Female
Europe Contraceptives Market: Players Segment Analysis (Company and Product introduction, Contraceptives Sales Volume, Revenue, Price and Gross Margin):
The Female Health Company
Teva Pharmaceutical
Reckitt Benckiser
Pfizer
Mayer Laboratories
Cooper Surgical
Church & Dwight
Actavis
Merck & Co.
In a word, the report provides detailed statistics and analysis on the state of the industry; and is a valuable source of guidance and direction for companies and individuals interested in the market.
Contraceptives-Europe Market Status and Trend Report 2013-2023 offers a comprehensive analysis on Contraceptives industry, standing on the readers’ perspective, delivering detailed market data and penetrating insights. No matter the client is industry insider, potential entrant or investor, the report will provides useful data and information. Key questions answered by this report include:
Whole Europe and Regional Market Size of Contraceptives 2013-2017, and development forecast 2018-2023
Main market players of Contraceptives in Europe, with company and product introduction, position in the Contraceptives market
Market status and development trend of Contraceptives by types and applications
Cost and profit status of Contraceptives, and marketing status
Market growth drivers and challenges
The report segments the Europe Contraceptives market as:
Europe Contraceptives Market: Regional Segment Analysis (Regional Consumption Volume, Consumption Volume, Revenue and Growth Rate 2013-2023)
Germany
United Kingdom
France
Italy
Spain
Benelux
Russia
Europe Contraceptives Market: Product Type Segment Analysis (Consumption Volume, Average Price, Revenue, Market Share and Trend 2013-2023):
Oral Contraceptive Pills
Injectables
Topical
Europe Contraceptives Market: Application Segment Analysis (Consumption Volume and Market Share 2013-2023; Downstream Customers and Market Analysis)
Male
Female
Europe Contraceptives Market: Players Segment Analysis (Company and Product introduction, Contraceptives Sales Volume, Revenue, Price and Gross Margin):
The Female Health Company
Teva Pharmaceutical
Reckitt Benckiser
Pfizer
Mayer Laboratories
Cooper Surgical
Church & Dwight
Actavis
Merck & Co.
In a word, the report provides detailed statistics and analysis on the state of the industry; and is a valuable source of guidance and direction for companies and individuals interested in the market.
CHAPTER 1 OVERVIEW OF CONTRACEPTIVES
1.1 Definition of Contraceptives in This Report
1.2 Commercial Types of Contraceptives
1.2.1 Oral Contraceptive Pills
1.2.2 Injectables
1.2.3 Topical
1.3 Downstream Application of Contraceptives
1.3.1 Male
1.3.2 Female
1.4 Development History of Contraceptives
1.5 Market Status and Trend of Contraceptives 2013-2023
1.5.1 Europe Contraceptives Market Status and Trend 2013-2023
1.5.2 Regional Contraceptives Market Status and Trend 2013-2023
CHAPTER 2 EUROPE MARKET STATUS AND FORECAST BY REGIONS
2.1 Market Status of Contraceptives in Europe 2013-2017
2.2 Consumption Market of Contraceptives in Europe by Regions
2.2.1 Consumption Volume of Contraceptives in Europe by Regions
2.2.2 Revenue of Contraceptives in Europe by Regions
2.3 Market Analysis of Contraceptives in Europe by Regions
2.3.1 Market Analysis of Contraceptives in Germany 2013-2017
2.3.2 Market Analysis of Contraceptives in United Kingdom 2013-2017
2.3.3 Market Analysis of Contraceptives in France 2013-2017
2.3.4 Market Analysis of Contraceptives in Italy 2013-2017
2.3.5 Market Analysis of Contraceptives in Spain 2013-2017
2.3.6 Market Analysis of Contraceptives in Benelux 2013-2017
2.3.7 Market Analysis of Contraceptives in Russia 2013-2017
2.4 Market Development Forecast of Contraceptives in Europe 2018-2023
2.4.1 Market Development Forecast of Contraceptives in Europe 2018-2023
2.4.2 Market Development Forecast of Contraceptives by Regions 2018-2023
CHAPTER 3 EUROPE MARKET STATUS AND FORECAST BY TYPES
3.1 Whole Europe Market Status by Types
3.1.1 Consumption Volume of Contraceptives in Europe by Types
3.1.2 Revenue of Contraceptives in Europe by Types
3.2 Europe Market Status by Types in Major Countries
3.2.1 Market Status by Types in Germany
3.2.2 Market Status by Types in United Kingdom
3.2.3 Market Status by Types in France
3.2.4 Market Status by Types in Italy
3.2.5 Market Status by Types in Spain
3.2.6 Market Status by Types in Benelux
3.2.7 Market Status by Types in Russia
3.3 Market Forecast of Contraceptives in Europe by Types
CHAPTER 4 EUROPE MARKET STATUS AND FORECAST BY DOWNSTREAM INDUSTRY
4.1 Demand Volume of Contraceptives in Europe by Downstream Industry
4.2 Demand Volume of Contraceptives by Downstream Industry in Major Countries
4.2.1 Demand Volume of Contraceptives by Downstream Industry in Germany
4.2.2 Demand Volume of Contraceptives by Downstream Industry in United Kingdom
4.2.3 Demand Volume of Contraceptives by Downstream Industry in France
4.2.4 Demand Volume of Contraceptives by Downstream Industry in Italy
4.2.5 Demand Volume of Contraceptives by Downstream Industry in Spain
4.2.6 Demand Volume of Contraceptives by Downstream Industry in Benelux
4.2.7 Demand Volume of Contraceptives by Downstream Industry in Russia
4.3 Market Forecast of Contraceptives in Europe by Downstream Industry
CHAPTER 5 MARKET DRIVING FACTOR ANALYSIS OF CONTRACEPTIVES
5.1 Europe Economy Situation and Trend Overview
5.2 Contraceptives Downstream Industry Situation and Trend Overview
CHAPTER 6 CONTRACEPTIVES MARKET COMPETITION STATUS BY MAJOR PLAYERS IN EUROPE
6.1 Sales Volume of Contraceptives in Europe by Major Players
6.2 Revenue of Contraceptives in Europe by Major Players
6.3 Basic Information of Contraceptives by Major Players
6.3.1 Headquarters Location and Established Time of Contraceptives Major Players
6.3.2 Employees and Revenue Level of Contraceptives Major Players
6.4 Market Competition News and Trend
6.4.1 Merger, Consolidation or Acquisition News
6.4.2 Investment or Disinvestment News
6.4.3 New Product Development and Launch
CHAPTER 7 CONTRACEPTIVES MAJOR MANUFACTURERS INTRODUCTION AND MARKET DATA
7.1 The Female Health Company
7.1.1 Company profile
7.1.2 Representative Contraceptives Product
7.1.3 Contraceptives Sales, Revenue, Price and Gross Margin of The Female Health Company
7.2 Teva Pharmaceutical
7.2.1 Company profile
7.2.2 Representative Contraceptives Product
7.2.3 Contraceptives Sales, Revenue, Price and Gross Margin of Teva Pharmaceutical
7.3 Reckitt Benckiser
7.3.1 Company profile
7.3.2 Representative Contraceptives Product
7.3.3 Contraceptives Sales, Revenue, Price and Gross Margin of Reckitt Benckiser
7.4 Pfizer
7.4.1 Company profile
7.4.2 Representative Contraceptives Product
7.4.3 Contraceptives Sales, Revenue, Price and Gross Margin of Pfizer
7.5 Mayer Laboratories
7.5.1 Company profile
7.5.2 Representative Contraceptives Product
7.5.3 Contraceptives Sales, Revenue, Price and Gross Margin of Mayer Laboratories
7.6 Cooper Surgical
7.6.1 Company profile
7.6.2 Representative Contraceptives Product
7.6.3 Contraceptives Sales, Revenue, Price and Gross Margin of Cooper Surgical
7.7 Church & Dwight
7.7.1 Company profile
7.7.2 Representative Contraceptives Product
7.7.3 Contraceptives Sales, Revenue, Price and Gross Margin of Church & Dwight
7.8 Actavis
7.8.1 Company profile
7.8.2 Representative Contraceptives Product
7.8.3 Contraceptives Sales, Revenue, Price and Gross Margin of Actavis
7.9 Merck & Co.
7.9.1 Company profile
7.9.2 Representative Contraceptives Product
7.9.3 Contraceptives Sales, Revenue, Price and Gross Margin of Merck & Co.
CHAPTER 8 UPSTREAM AND DOWNSTREAM MARKET ANALYSIS OF CONTRACEPTIVES
8.1 Industry Chain of Contraceptives
8.2 Upstream Market and Representative Companies Analysis
8.3 Downstream Market and Representative Companies Analysis
CHAPTER 9 COST AND GROSS MARGIN ANALYSIS OF CONTRACEPTIVES
9.1 Cost Structure Analysis of Contraceptives
9.2 Raw Materials Cost Analysis of Contraceptives
9.3 Labor Cost Analysis of Contraceptives
9.4 Manufacturing Expenses Analysis of Contraceptives
CHAPTER 10 MARKETING STATUS ANALYSIS OF CONTRACEPTIVES
10.1 Marketing Channel
10.1.1 Direct Marketing
10.1.2 Indirect Marketing
10.1.3 Marketing Channel Development Trend
10.2 Market Positioning
10.2.1 Pricing Strategy
10.2.2 Brand Strategy
10.2.3 Target Client
10.3 Distributors/Traders List
CHAPTER 11 REPORT CONCLUSION
CHAPTER 12 RESEARCH METHODOLOGY AND REFERENCE
12.1 Methodology/Research Approach
12.1.1 Research Programs/Design
12.1.2 Market Size Estimation
12.1.3 Market Breakdown and Data Triangulation
12.2 Data Source
12.2.1 Secondary Sources
12.2.2 Primary Sources
12.3 Reference
1.1 Definition of Contraceptives in This Report
1.2 Commercial Types of Contraceptives
1.2.1 Oral Contraceptive Pills
1.2.2 Injectables
1.2.3 Topical
1.3 Downstream Application of Contraceptives
1.3.1 Male
1.3.2 Female
1.4 Development History of Contraceptives
1.5 Market Status and Trend of Contraceptives 2013-2023
1.5.1 Europe Contraceptives Market Status and Trend 2013-2023
1.5.2 Regional Contraceptives Market Status and Trend 2013-2023
CHAPTER 2 EUROPE MARKET STATUS AND FORECAST BY REGIONS
2.1 Market Status of Contraceptives in Europe 2013-2017
2.2 Consumption Market of Contraceptives in Europe by Regions
2.2.1 Consumption Volume of Contraceptives in Europe by Regions
2.2.2 Revenue of Contraceptives in Europe by Regions
2.3 Market Analysis of Contraceptives in Europe by Regions
2.3.1 Market Analysis of Contraceptives in Germany 2013-2017
2.3.2 Market Analysis of Contraceptives in United Kingdom 2013-2017
2.3.3 Market Analysis of Contraceptives in France 2013-2017
2.3.4 Market Analysis of Contraceptives in Italy 2013-2017
2.3.5 Market Analysis of Contraceptives in Spain 2013-2017
2.3.6 Market Analysis of Contraceptives in Benelux 2013-2017
2.3.7 Market Analysis of Contraceptives in Russia 2013-2017
2.4 Market Development Forecast of Contraceptives in Europe 2018-2023
2.4.1 Market Development Forecast of Contraceptives in Europe 2018-2023
2.4.2 Market Development Forecast of Contraceptives by Regions 2018-2023
CHAPTER 3 EUROPE MARKET STATUS AND FORECAST BY TYPES
3.1 Whole Europe Market Status by Types
3.1.1 Consumption Volume of Contraceptives in Europe by Types
3.1.2 Revenue of Contraceptives in Europe by Types
3.2 Europe Market Status by Types in Major Countries
3.2.1 Market Status by Types in Germany
3.2.2 Market Status by Types in United Kingdom
3.2.3 Market Status by Types in France
3.2.4 Market Status by Types in Italy
3.2.5 Market Status by Types in Spain
3.2.6 Market Status by Types in Benelux
3.2.7 Market Status by Types in Russia
3.3 Market Forecast of Contraceptives in Europe by Types
CHAPTER 4 EUROPE MARKET STATUS AND FORECAST BY DOWNSTREAM INDUSTRY
4.1 Demand Volume of Contraceptives in Europe by Downstream Industry
4.2 Demand Volume of Contraceptives by Downstream Industry in Major Countries
4.2.1 Demand Volume of Contraceptives by Downstream Industry in Germany
4.2.2 Demand Volume of Contraceptives by Downstream Industry in United Kingdom
4.2.3 Demand Volume of Contraceptives by Downstream Industry in France
4.2.4 Demand Volume of Contraceptives by Downstream Industry in Italy
4.2.5 Demand Volume of Contraceptives by Downstream Industry in Spain
4.2.6 Demand Volume of Contraceptives by Downstream Industry in Benelux
4.2.7 Demand Volume of Contraceptives by Downstream Industry in Russia
4.3 Market Forecast of Contraceptives in Europe by Downstream Industry
CHAPTER 5 MARKET DRIVING FACTOR ANALYSIS OF CONTRACEPTIVES
5.1 Europe Economy Situation and Trend Overview
5.2 Contraceptives Downstream Industry Situation and Trend Overview
CHAPTER 6 CONTRACEPTIVES MARKET COMPETITION STATUS BY MAJOR PLAYERS IN EUROPE
6.1 Sales Volume of Contraceptives in Europe by Major Players
6.2 Revenue of Contraceptives in Europe by Major Players
6.3 Basic Information of Contraceptives by Major Players
6.3.1 Headquarters Location and Established Time of Contraceptives Major Players
6.3.2 Employees and Revenue Level of Contraceptives Major Players
6.4 Market Competition News and Trend
6.4.1 Merger, Consolidation or Acquisition News
6.4.2 Investment or Disinvestment News
6.4.3 New Product Development and Launch
CHAPTER 7 CONTRACEPTIVES MAJOR MANUFACTURERS INTRODUCTION AND MARKET DATA
7.1 The Female Health Company
7.1.1 Company profile
7.1.2 Representative Contraceptives Product
7.1.3 Contraceptives Sales, Revenue, Price and Gross Margin of The Female Health Company
7.2 Teva Pharmaceutical
7.2.1 Company profile
7.2.2 Representative Contraceptives Product
7.2.3 Contraceptives Sales, Revenue, Price and Gross Margin of Teva Pharmaceutical
7.3 Reckitt Benckiser
7.3.1 Company profile
7.3.2 Representative Contraceptives Product
7.3.3 Contraceptives Sales, Revenue, Price and Gross Margin of Reckitt Benckiser
7.4 Pfizer
7.4.1 Company profile
7.4.2 Representative Contraceptives Product
7.4.3 Contraceptives Sales, Revenue, Price and Gross Margin of Pfizer
7.5 Mayer Laboratories
7.5.1 Company profile
7.5.2 Representative Contraceptives Product
7.5.3 Contraceptives Sales, Revenue, Price and Gross Margin of Mayer Laboratories
7.6 Cooper Surgical
7.6.1 Company profile
7.6.2 Representative Contraceptives Product
7.6.3 Contraceptives Sales, Revenue, Price and Gross Margin of Cooper Surgical
7.7 Church & Dwight
7.7.1 Company profile
7.7.2 Representative Contraceptives Product
7.7.3 Contraceptives Sales, Revenue, Price and Gross Margin of Church & Dwight
7.8 Actavis
7.8.1 Company profile
7.8.2 Representative Contraceptives Product
7.8.3 Contraceptives Sales, Revenue, Price and Gross Margin of Actavis
7.9 Merck & Co.
7.9.1 Company profile
7.9.2 Representative Contraceptives Product
7.9.3 Contraceptives Sales, Revenue, Price and Gross Margin of Merck & Co.
CHAPTER 8 UPSTREAM AND DOWNSTREAM MARKET ANALYSIS OF CONTRACEPTIVES
8.1 Industry Chain of Contraceptives
8.2 Upstream Market and Representative Companies Analysis
8.3 Downstream Market and Representative Companies Analysis
CHAPTER 9 COST AND GROSS MARGIN ANALYSIS OF CONTRACEPTIVES
9.1 Cost Structure Analysis of Contraceptives
9.2 Raw Materials Cost Analysis of Contraceptives
9.3 Labor Cost Analysis of Contraceptives
9.4 Manufacturing Expenses Analysis of Contraceptives
CHAPTER 10 MARKETING STATUS ANALYSIS OF CONTRACEPTIVES
10.1 Marketing Channel
10.1.1 Direct Marketing
10.1.2 Indirect Marketing
10.1.3 Marketing Channel Development Trend
10.2 Market Positioning
10.2.1 Pricing Strategy
10.2.2 Brand Strategy
10.2.3 Target Client
10.3 Distributors/Traders List
CHAPTER 11 REPORT CONCLUSION
CHAPTER 12 RESEARCH METHODOLOGY AND REFERENCE
12.1 Methodology/Research Approach
12.1.1 Research Programs/Design
12.1.2 Market Size Estimation
12.1.3 Market Breakdown and Data Triangulation
12.2 Data Source
12.2.1 Secondary Sources
12.2.2 Primary Sources
12.3 Reference
